Skip to content

WEREWOLF THERAPEUTICS, INC.

HOWL

CIK 0001785530

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$65.97M
+13.7% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.44
+18.4% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$55.05M
Q1 May 2026
Cash
$46.45M
Q1 May 2026
Total Debt
$32.09M
Q1 May 2026
Shares Outstanding
48.6M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings